US exceeds 700 measles cases amid national outbreaks How many cases are in Oklahoma?
The U.S. reached a grim milestone Friday, surpassing 700 confirmed measles cases in 2025, according to figures posted by the Centers for Disease Control and Prevention. The year before, only 285 cases were reported nationwide.
So far, the agency has reported cases in two dozen states, with Texas reporting more than 540 measles cases. Oklahoma, however, only accounts for about 2% of the total cases in the nation.
There have been two deaths in the U.S. linked to measles, while one more is currently under investigation.
The rapidly spreading disease is making its way through the nation and has already entered Oklahoma's borders. Here's what to know about measles nationwide and in the Sooner State.
Though the CDC has reported more cases this year, it also states that cases are found in fewer states. This year, only 24 states have reported measles cases, compared to 33 in 2024.
There have also been fewer outbreaks that have occurred throughout the nation this year. Only seven outbreaks have been reported in 2025, and 93% of the cases that have been reported are related to one of the outbreaks.
In 2024, the CDC reported 16 outbreaks throughout the year, with 69% of cases related to an outbreak. The CDC defines outbreaks as three or more related cases.
Of those confirmed with the measles virus, the majority of the age range is those aged 5-19. This population makes up 38% of cases, with 274 unique confirmations.
The overwhelming majority of cases have been found in unvaccinated individuals. Only 3% of cases have been found in individuals with one (1%) or both (2%) MMR doses.
The Oklahoma State Department of Health has continued to report measles cases as they are recorded and issues exposure notices as necessary.
The most recent report, from April 15, states there have been 12 measles cases reported in Oklahoma. Nine cases are confirmed cases, meaning the lab has a confirmatory test result from the individual, and three are probable cases, when the lab does not yet have the confirmatory test.
All 12 cases are among unvaccinated individuals.
This month, the OSDH shared two exposure notices.
Northwest Pediatrics of Oklahoma City's Mercy Plaza Building, 4140 W. Memorial Rd., for anyone visiting between 10:45 a.m. to 2 p.m. on Friday, April 4.
Aldi Grocery Store, 6965 Northwest Expressway, between 10 a.m. and 1 p.m. on Sunday, April 6.
The health department reports that anyone who visited either location within the stated dates and timeframes, unsure of their vaccination status or not vaccinated against measles should contact the health department by calling 405-426-8000 between 8 a.m. and 8 p.m.
Individuals possibly exposed and not immune through vaccination or prior infections should exclude themselves from public settings for 21 days after their potential exposure.
Notices are updated online at oklahoma.gov.
If you do not know your vaccination status, you can look for your MMR vaccine record by checking your shot records with the state Health Department at https://tinyurl.com/shot-records.
This article originally appeared on Oklahoman: Measles outbreak: US exceeds 700 cases in 2025, Oklahoma cases rising
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
34 minutes ago
- Yahoo
New Mexico health officials: Measles sample detected in Roswell wastewater testing
(Rimma Bondarenko/ Getty Images) New Mexico public health officials on Tuesday announced wastewater testing in Roswell had identified a positive sample for measles. A state health department news release said the June 3 sample result will not impact the number of cases in the state, which requires a diagnosis and often a laboratory confirmation of a sample taken from a person. The sample comes as part of a wastewater testing initiative NMDOH undertook starting in mid-March, conducting weekly wastewater measles testing in Albuquerque/Bernalillo County, Carlsbad, Chaparral, Deming, Las Cruces, Portales, Rincon, Rio Rancho, Roswell, Santa Fe and the South Central treatment plant in Doña Ana County. In an interview with Source NM, NMDOH Medical Epidemiologist Dr. Daniel Sosin said the agency is partnering with researchers at Rice University in Houston Texas for that testing. The wastewater results have limits, and don't reveal when, where or even how many people might have measles. But they do provide warning. In this case, the positive result from Roswell indicates more cases might be coming in Chaves County, NMDOH says. Chaves County 's last measles case was recorded on April 5. As of Tuesday, New Mexico measles infections remain unchanged at 81 cases. Sosin said the wastewater testing program augments the department's strategies for increasing vaccine availability and contract-tracing known cases, and likened the approach to layers of Swiss cheese. 'If you have enough slices, you cover the holes so cases don't slip through,' Sosin said. 'Wastewater is one more layer that helps us monitor for a condition that we don't expect to see in all parts of the state, but could see and want early recognition for.' Sosin said measles wastewater testing is better for early detection or asymptomatic spread, and those detections could mean putting area doctors on alert for additional cases. The major limitation of wastewater surveillance, he said, is the tool is only precise for a general picture and cannot be narrowed further. 'We can't follow up for contact tracing or notifications to reduce ongoing transmission,' Sosin said. 'It's really more of an indicator that [measles] is there and we should be watching more carefully for it.' Sosin said the best guidance to the public remains the recommendation to get two doses of the vaccine to prevent contracting and spreading the measles. The state says since Feb. 1, 34,210 New Mexicans have received MMR shots. Measles symptoms can appear one to three weeks after contact with airborne droplets from an infected person's coughs or sneezes. They include fever, cough, red eyes usually followed by a spotted red rash spreading from the head to the body. Measles can be spread in days before and after symptoms emerge. NMDOH urges any people with symptoms to stay at home and contact the NMDOH Helpline at 1-833-796-8773 for further questions about testing, vaccines or treatment. SUBSCRIBE: GET THE MORNING HEADLINES DELIVERED TO YOUR INBOX
Yahoo
34 minutes ago
- Yahoo
Positive measles sample found in Roswell wastewater testing
ROSWELL, N.M. (KRQE) — The New Mexico Department of Health confirmed on Tuesday that a positive measles sample was found through wastewater testing in Roswell. The sample was taken on June 3 as part of a wastewater testing initiative that has been conducted in 11 treatment facilities around New Mexico since March. Story continues below New Mexico Crime Files: Grocery store worker hands out semen-tainted yogurt Film: These productions were filmed at White Sands. Have you seen them? New Mexico News Insiders: Who Will Fix New Mexico's Mental Health Problems? News: Governor's Office: Operation Zia Shield is different than situation in California The sample does not represent an official measles case, according to the NMDOH. However, the department says it serves as a reminder for Chaves County residents to check on their MMR vaccination. There are currently 81 measles cases reported in New Mexico. The last laboratory-confirmed case in Chaves County was on April 5. 'While wastewater testing cannot tell us the timing, location or number of people infected with measles, this detection tells us there was at least one person infectious with measles in Roswell around June 3 and puts us on notice there may be more cases in Chaves County in the coming days,' said Dr. Daniel Sosin, NMDOH medical epidemiologist. NMDOH carries out weekly wastewater measles testing in Albuquerque/Bernalillo County, Carlsbad, Chaparral, Deming, Las Cruces, Portales, Rincon, Rio Rancho, Roswell, Santa Fe and the South Central treatment plant in Doña Ana County. Symptoms of measles include fever, cough, runny nose and red eyes, followed by a red spotted rash that usually starts on the head or face and spreads down the body. Anyone with symptoms is asked to stay home and contact their health provider, or the NMDOH Helpline at 1-833-SWNURSE (1-833-796-8773). Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Miami Herald
an hour ago
- Miami Herald
Domino's Pizza, McDonald's rating surprise tied to persistent consumer issue
Even the Hamburglar didn't see this one coming. Excessive weight has been a persistent problem in America, where at least one in five adults in each U.S. state is living with obesity, according to the Centers for Disease Control and Prevention. Don't miss the move: Subscribe to TheStreet's free daily newsletter As obesity rates have risen, so have scientists' efforts to address this serious health issue, which can cause asthma, heart disease, stroke, type 2 diabetes and even some cancers. Early attempts to treat obesity came to the market as early as the 1930s. Amphetamines were the prevalent treatment in the 1940s and 1950s and demand continued into the 1990s. Glucagon-like peptide-1 agonists, which mimic the action of the naturally occurring hormone GLP-1, have been available for about two decades. GLP-1 medications, including Ozempic, Wegovy, Zepbound and Mounjaro, have been used for years to treat Type 2 diabetes, and studies have found that they are also effective at encouraging weight loss. Wegovy and Ozempic are manufactured by Novo Nordisk (NVO) , while Eli Lilly (LLY) makes Zepbound and Mounjaro. Image source:One investment firm says increased use of these medications could have serious implications for two of the biggest names in the fast-food industry: McDonald's (MCD) and Domino's Pizza (DPZ) . The market for anti-obesity drugs, particularly those using injectable versions of GLP 1-based drugs, is still new and continuously evolving, Goldman Sachs said in a May 22 report. More Restaurants Beloved Mexican restaurant closing iconic location after 63 yearsMajor restaurant chain quietly closes several locationsIconic restaurant closing its doors after 32 years The investment firm lowered its projections for such medication and now forecasts the global market to reach $95 billion by 2030. That's down from the previous estimate of $130 billion to reflect trends influencing how the drugs are priced, how long patients stay on them, and how patient populations are segmented. Goldman lowered its U.S. market projections to a peak of $70 billion, but the firm sees room for greater penetration in markets outside the U.S. Goldman forecasts a market peak of $50 billion outside the US, compared with $35 billion previously. A survey of more than 50 doctors in the US found that lower doses of anti-obesity medications are working well for a majority of patients and insurance coverage is the most important factor in the decision-making process, Goldman Sachs wrote. "But to be clear, even with this moderated forecast, we see a significant growth opportunity for both existing players as well as new entrants into this market," said Asad Haider, head of the health-care business unit within Goldman Sachs Research. Demand for GPL-1 drugs could dramatically hinder the food and restaurant industries, according to a study from Cornell's SC Johnson College of Business and the data firm Numerator. The report, entitled "The No Hunger Games," found that households with at least one user of GLP-1 drugs reduced its grocery spending by about 6% within six months of starting the drugs. The spending cut was as much as 9% for higher-income households. "We also find an 8.6% decline in spending at fast-food chains, coffee shops and limited-service restaurants," the study said. "Our findings highlight the potential for GLP-1 medications to significantly change food demand, a trend with increasingly important implications for the food industry as GLP-1 adoption continues to grow." The study warned that common side effects of GLP-1 medications, such as nausea, vomiting and gastrointestinal discomfort, have reportedly led to reduced adherence or discontinued use for some patients. Related: McDonald's analyst grills new stock price target on McCrispy reaction "Moreover, their long-term efficacy and safety remain areas of ongoing investigation," the report said. Redburn Atlantic analyst Chris Luyckx focused on the growing adoption of GLP-1 in recent research reports. Luyckx double-downgraded McDonald's to sell from buy with a price target of $260, down from $319. The analyst expects the GLP-1 weight-loss drugs to suppress consumer appetites and says they present an underappreciated longer-term threat for McDonald's. A 1% drag on sales today "could easily build to 10% or more over time," particularly for restaurant brands skewed toward lower-income consumers, the analyst tells investors in a research note. McDonald's stock was down about 1.3% at last check and is up 18.5% from a year ago. Redburn Atlantic also initiated coverage of Domino's Pizza with a sell rating and $340 price target. Domino's, the world's largest pizza chain, faces the heaviest pressure from adoption of GLP-1 weight loss drugs, with high exposure to dinner occasions and lower-income consumers, the firm said. Redburn Atlantic said the company's organic traffic remains weak, with carry-out far outpacing delivery. Challenged system-sales growth and elevated consensus expectations present downside risk for Domino's, the firm said. McDonald's closed regular trading on June 10 down 1.4% at $300.43. Domino's shares were off 2.7% at $455.49. Related: Fund-management veteran skips emotion in investment strategy The Arena Media Brands, LLC THESTREET is a registered trademark of TheStreet, Inc.
